- ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants with HIV-1 RNA <500000 Copies/mL. Physical Review C - Nuclear Physics. 2018 Academic Article GET IT
Pharmacogenomics of HIV therapy: Summary of a workshop sponsored by the National Institute of allergy and infectious diseases.
HIV Clinical Trials.
Times cited: 14
Identification of the bacterial etiology of culture-negative endocarditis by amplification and sequencing of a small ribosomal RNA gene.
Diagnostic Microbiology and Infectious Disease.
Times cited: 8